dc.contributor.author
Assmann, Nele
dc.contributor.author
Kaiser, Tim
dc.contributor.author
Herzog, Philipp
dc.contributor.author
Arntz, Arnoud
dc.contributor.author
Klein, Jan Philipp
dc.contributor.author
Fassbinder, Eva
dc.contributor.author
Schaich, Anja
dc.date.accessioned
2026-01-14T13:07:56Z
dc.date.available
2026-01-14T13:07:56Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/51108
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-50835
dc.description.abstract
Background
Borderline personality disorder (BPD) can be treated successfully with specific psychological treatments, but there is no clear evidence of superiority of one specific treatment at the group level. Due to high heterogeneity in BPD, individual patients might benefit differently from specific treatments.
Methods
Based on a randomised trial comparing 18 months of dialectical behaviour therapy (DBT) and schema therapy (ST) for BPD, differential effectiveness was examined using causal forest analyses. Baseline variables on BPD criteria, general psychopathology, traumatic childhood experiences, rejection sensitivity, level of functioning, coping skills, schemas and medication were included to predict the Borderline Personality Disorder Severity Index (BPDSI-IV) during treatment and follow-up (24 and 30 months after start of treatment).
Results
A subgroup was identified that benefited significantly more from DBT compared to ST. This group showed a significantly greater reduction in symptoms post treatment (post-treatment difference of 5.79 BPDSI points, SMD = 0.65, p = .028), but no longer at follow-up (p = .771). The group that showed better results with DBT displayed a pattern of specific baseline characteristics: higher levels of functioning, less frequent emotional neglect and sexual abuse, more severe anxiety symptoms and more pronounced schema ’failure to achieve’. No pattern of variables was identified associated with a superiority of ST.
Conclusion
Moderators of the short-term effect of DBT versus ST were found. However, this moderator effect was no longer significant at follow-up. Identifying patient characteristics associated with differential treatment effect might be a promising way to improve BPD treatment outcomes faster.
Retrospectively registered (German Clinical Trials Register: DRKS00011534) without protocol changes.
en
dc.format.extent
8 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Borderline personality disorder
en
dc.subject
Differential effectiveness
en
dc.subject
Treatment heterogeneity
en
dc.subject
Dialectical behaviour therapy
en
dc.subject
Schema therapy
en
dc.subject
Personalized advantage index
en
dc.subject.ddc
100 Philosophie und Psychologie::150 Psychologie::150 Psychologie
dc.title
Differential effectiveness of dialectical behavioural therapy and schema therapy in patients with borderline personality disorder: a secondary analysis of a randomised clinical trial
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
104899
dcterms.bibliographicCitation.doi
10.1016/j.brat.2025.104899
dcterms.bibliographicCitation.journaltitle
Behaviour Research and Therapy
dcterms.bibliographicCitation.volume
195
dcterms.bibliographicCitation.url
https://doi.org/10.1016/j.brat.2025.104899
refubium.affiliation
Erziehungswissenschaft und Psychologie
refubium.affiliation.other
Arbeitsbereich Methoden und Evaluation/Qualitätssicherung

refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1873-622X
refubium.resourceType.provider
WoS-Alert